Business & Products
Pharmaceutical manufacturing company specializing in Hanmi Fine Chemical
Hanmi Fine Chemical is a global supplier of active pharmaceutical ingredients (APIs) with vast experience, outstanding technology and superior synthesis and quality control systems in API production. We manufacture sterile and non-sterile cephalosporin-based products and general APIs. With the establishment of a cGMP-certified plant with the latest equipment and facilities in 2007 for API manufacture, we have acquired large-scale production capacity and the necessary equipment, facilities and technological power to become a contract manufacturing organization (CMO).
Recently, we have established a new projects division to perform R&D projects on new materials for OLED, display semi-conductors, etc. with an aim to open a brighter future for our company.
- Manufacturing of sterile cephalosporin-based APIs
- Manufacturing of general cephalosporin-based APIs
- Synthesis of various APIs
- R&D on intermediate substances and synthesis thereof
- R&D on chemical synthesis for various industries
- OLED materials
- Display semiconductor materials
- Other environmental materials
- cGMP-certified plants
- Facilities that can meet the demand with flexibility
- Production capacity of 300,000L
- Operation of a division dedicated to the CRO business
- Chemical Synthesis
- Analytical Methods
World Wide Business
Hanmi Fine Chemical has been manufacturing APIs since 1987 and supplying it to more than 100 client companies in 40 countries all over the world. We have exported to European countries such as the United Kingdom, Germany, France, Italy, Spain, Slovenia, and Poland, and Asian countries such as China, Japan, Thailand, India, Indonesia, Pakistan, Turkey, Jordan, and Iran. In the Americas, we have clients in the United States, Mexico, Argentina, Brazil, Colombia, Chile and etc.
With the newly established large-scale production facilities, we have acquired the capacity to produce and supply more innovative APIs and intermediates. Based on our competency, we will continue to pioneer the global market with major pharmaceutical companies and exporting partners.